FIA
ATYR

FNY Investment Advisers’s aTyr Pharma ATYR Stock Holding History

FNY Investment Advisers’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1,500
– – ﹤0.01% 1088
2026
Q1 		$1K Sell
1,500
-3,300
-69% -$2.79K ﹤0.01% 731
2025
Q4 		$3K Buy
4,800
+4,100
+586% +$3.37K ﹤0.01% 789
2025
Q3 		$0 Buy
+700
New +$3.17K ﹤0.01% 1573

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FNY Investment Advisers's ATYR Position: Q2 2026 in Review

FNY Investment Advisers held its aTyr Pharma (ATYR) position steady in Q2 2026 at 1,500 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

FNY Investment Advisers first reported a position in ATYR in Q3 2025 and has held it in 4 quarters since. The position peaked at $3K in Q4 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • FNY Investment Advisers held 1,500 shares of aTyr Pharma worth $0 as of Q2 2026.
  • FNY Investment Advisers left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #1088 holding.
  • FNY Investment Advisers first reported a position in aTyr Pharma in Q3 2025 and has held it in 4 quarters since.
  • FNY Investment Advisers's aTyr Pharma position peaked at $3K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.